ReviewBiomolecules2026

Nuclear Receptor-Targeted Therapies: Reprogramming Metabolism with TRβ, ERRα, and LXR Modulators.

Carmen Di Giovanni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.